MONTAGNANI FRANCESCA

Francesca
Montagnani
Professore Associato

Presentation

Francesca Montagnani is Associate Professor in Infectious Diseases at the Department of Medical Biotechnology of the University of Siena.

Her research activity is mainly focused on antibiotic resistance, prophylaxis and treatment of infections in immunosuppressed patients, lung transplant recipients and SARSCov2 infection. She coordinates and participates in national multicenter studies on the infectious disease management of lung transplant recipients within LungSITO (lung section of the Italian Organ Transplant Society), of which she is a member as a representative of Italian Infectiuos Diseases Specilaist who deal with lung transplantation.

She also participates in projects relating to patients infected with major hepatotropic viruses and HIV-HCV co-infected.

Office hours

Appointments can be scheduled via email request

Contacts

Curriculum Vitae

Teaching activities

Completion accademic year: 2024/2025

Course year: 3 First cycle degree (DM 270) CARDIOCIRCULATORY AND CARDIOVASCULAR PERFUSION TECHNIQUES A.Y. 2022/2023
Course year: 3 Full cicle (6 years) DENTISTRY AND DENTAL PROSTHODONTICS A.Y. 2022/2023

Completion accademic year: 2023/2024

Course year: 2 First cycle degree (DM 270) NURSING A.Y. 2022/2023
Course year: 3 First cycle degree (DM 270) CARDIOCIRCULATORY AND CARDIOVASCULAR PERFUSION TECHNIQUES A.Y. 2021/2022
Course year: 4 IGIENE E MEDICINA PREVENTIVA A.Y. 2020/2021
Course year: 3 Full cicle (6 years) DENTISTRY AND DENTAL PROSTHODONTICS A.Y. 2021/2022

Completion accademic year: 2022/2023

Course year: 1 First cycle degree (DM 270) ENVIRONMENT AND WORKPLACE PREVENTION TECHNIQUES A.Y. 2022/2023
Course year: 2 First cycle degree (DM 270) NURSING A.Y. 2021/2022
Course year: 3 First cycle degree (DM 270) CARDIOCIRCULATORY AND CARDIOVASCULAR PERFUSION TECHNIQUES A.Y. 2020/2021
Course year: 4 IGIENE E MEDICINA PREVENTIVA A.Y. 2019/2020

Research

Ultime pubblicazioni:

  • Giuliano, G., Lippi, A., Sambo, M., Dulislami, L., Zanchi, M., Bennett, D., et al. (2026). Treatment of post-lung transplantation pneumonia with cefiderocol: a case series and insights from the literature. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 45(4), 1177-1184 [10.1007/s10096-025-05385-1]. - view more
  • Micheli, G., Mondi, A., Roen, A., Taramasso, L., Luchetti, I., Mazzotta, V., et al. (2026). Did the COVID-19 pandemic shift the landscape of late HIV diagnosis?. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 165 [10.1016/j.ijid.2026.108437]. - view more
  • D'Arminio Monforte, A., Lentini, N., Tavelli, A., Rusconi, S., Sozio, F., Guida, A., et al. (2026). Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500 000 copies/mL in 2018–2023 in Italy: data from the ICONA Foundation Cohort Study. CLINICAL MICROBIOLOGY AND INFECTION, 32(5), 866-869 [10.1016/j.cmi.2026.01.007]. - view more
  • Vergori, A., Cervo, A., Roen, A., Gagliardini, R., Clemente, T., Mazzotta, V., et al. (2026). Risk of developing low-level viral rebound among people with HIV receiving 2- or 3-drug regimens: a case-control study nested in the ICONA cohort. OPEN FORUM INFECTIOUS DISEASES, 13(5) [10.1093/ofid/ofag250]. - view more
  • Montagnani, F., Lombardi, A., Mularoni, A., Docquier, J., Marchesi, F. (2026). Editorial: Multidrug-resistant Gram-negative bacteria in fragile hosts. FRONTIERS IN MICROBIOLOGY, 17 [10.3389/fmicb.2026.1865417]. - view more